Clinical value of ultra-low dose computed tomography compared to chest X-ray investigations in diagnosing pulmonary pathology

Clinical value of ultra-low dose computed tomography compared to chest X-ray investigations in diagnosing pulmonary pathology - Ultra low-dose CT in diagnosing pulmonary pathology

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43362

Enrollment

200

Registered

2016-06-29

Start date

2016-07-07

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Pathologie

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * 50 years. Referral for Chest x-ray. Having given written informed consent prior to undertaking any study-related procedures.

Exclusion criteria

Exclusion criteria: BMI * 30. Patients who are not capable of to hold breath for at least 5 seconds. Pregnancy.

Design outcomes

Primary

Measure	Time frame
- Percentages of pulmonary pathology detected by ULDCT as compared to CXR.	—

Secondary

Measure	Time frame
- Number of patients which have an added clinical value of ULDCT by means of (potential) changes in clinical decision as compared to CXR examination. - Analyse the cost-effect when implementing ULDCT instead of CXR. - To analyse the reconstruction algorithm influence on the clinical detection probability in ULDCT: AIDR3D versus FIRST	—

Countries

Netherlands

Outcome results